反复暴露于林纳的氧化物诱导免疫学验证过敏接触性皮肤炎
Sofia Botvid1,2, Niels Højsager Bennike1,2, Jeanne Duus Johansen1,2
1The National Allergy Research Centre (Videncenter for Allergi), Department of Allergy, Dermatology and Venerology, Copenhagen University Hospital Herlev-Gentofte, Gentofte Hospital, Hellerup, Denmark.
Contact dermatitis
|February 19, 2026
概括
林醇氧化物 (Lin-OOH) 引起接触过敏. 这项研究重新评估了Lin-OOH贴片试验度,并发现1.0%可靠,在模拟使用期间对敏感个体产生剂量依赖反应.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 毒理学 毒理学 毒理学
背景情况:
- 香味过敏原,如林纳醇氧化物 (Lin-OOH),是接触过敏 (CA) 的重要原因.
- 产品中的林纳醇形成的Lin-OOH经常与阳性贴片测试有关,但可能引起模两可或刺激反应.
- 目前对Lin-OOH的贴片试验度可能不准确地反映临床敏感性.
研究的目的:
- 在诊断接触过敏时优化Lin-OOH的贴片试验度.
- 在重复暴露条件下确定Lin-OOH的诱导值.
- 调查林-OOH诱导的过敏性接触性皮肤炎背后的免疫机制.
主要方法:
- 在怀疑CA的个体和健康对照人身上进行了各种Lin-OOH度的贴片测试.
- 进行了21天的重复开放应用试验 (ROAT),使用不同度的Lin-OOH模拟香水.
- 从使用RT-qPCR评估免疫基因表达的参与者的子集分析皮肤活检.
主要成果:
- 1.0%的Lin-OOH度被证明是最有效的证实患者队列中的CA.
- 在0.018% (179 ppm) 的度下,在敏感的个体中观察到积极的ROAT反应,证明了剂量依赖的反应.
- 基因表达分析显示,IL1家族成员,II型免疫反应标记物 (IL4,GATA3) 和化学因子 (CCL22) 在应对Lin-OOH暴露时的上调.
结论:
- 在敏感的个体中,Lin-OOH会引起剂量依赖的过敏反应,无论是在贴片试验中还是在模拟产品使用 (ROAT) 期间.
- 该研究确定了可靠的补丁试验度,并确定了Lin-OOH的诱导值.
- 分子分析证实了过敏接触性皮肤炎特征的特定免疫通路的激活.
相关概念视频
02:06Allergic Reactions
26.4K
Overview
26.4K
01:27Allergic Drug Reactions
1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
01:30Hypersensitivities
7.3K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.3K
01:30Drug Toxicity: Allergic Reactions
209
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
209
01:30Allergic Reactions: Anaphylaxis
280
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
280
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
359
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
359